check / who pays

Will your plan pay? Ask it directly.

Give your insurer the precise product name, its form, pill or shot, and the condition it would treat. Ask what the plan will pay.

Get an answer tied to your proposed care.

Ask whether the visit and the medicine are covered separately. Request the conditions for each.

Ask whether the plan needs prior authorization: agreement to pay before the medicine is supplied.

Ask about its formulary, the list of medicines the plan covers.

Record who answered and what documents the clinician must send. Ask for a written response about your own plan.

For Medicare, check the use and the route.

Medicare Part D is Medicare's prescription medicine benefit.

Weight-loss medicines remain excluded from the ordinary benefit as of September 2026.a

As of September 2026, a medicine used for a different accepted condition may qualify for Part D, but the plan's own cover rules still apply.a

As of September 2026, the separate Medicare GLP-1 Bridge gives eligible Part D members access to certain weight medicines with a $50 monthly copay through December 31, 2027.b

The hormone GLP-1 carries chemical messages about appetite and blood sugar in the body; these medicines imitate what it does.

Read the Bridge limits before relying on that price.

Getting Bridge payment requires a prescription plus advance approval, known as prior authorization, as of September 2026.

The clinician must check your age, starting weight and height, health conditions, and Medicare plan against the programme's rules.

As of September 2026, eligibility requires an age of 18 or older and a qualifying Part D or Medicare Advantage plan with medicine coverage.

For the weight check, your height and weight give a figure called BMI, or body mass index.

As of September 2026, a BMI of 35 or more can qualify; a lower BMI requires certain other health problems.

The BMI 30 route requires particular heart failure, kidney disease of a specified severity, or blood pressure above the programme's limits despite two medicines.

With a BMI of 27 or above, qualifying problems include a past stroke, a past heart attack, pre-diabetes, or leg artery narrowing that causes symptoms.

These are summaries; ask the clinician to check the exact health condition and its severity in the official rules below.

Receiving Part D payment for one of these medicines during 2026 rules out your Bridge participation for 2026.c

The Bridge excludes people who have type 2 diabetes as of September 2026; their medicine use follows the ordinary Part D route instead.c

Under ordinary Part D, a yearly spending limit caps what you pay for covered prescription medicines.

As of September 2026, the Bridge's $50 monthly charge does not count towards that limit.

The $50 charge still applies even if you reach the limit for ordinary Part D.

Members on low incomes receive no extra help with this Bridge charge, as of September 2026.d

As of September 2026, the Bridge covers orforglipron (Foundayo), a tablet used for weight management.

As of September 2026, it also covers semaglutide (Wegovy), as tablets or shots.

As of September 2026, it covers tirzepatide (Zepbound) only in the KwikPen, a pen-shaped device for giving a shot.

The single-dose pens and small bottles called vials are excluded, as of September 2026.c

Ask the clinician and your plan which route fits the exact proposed product. Read the official eligibility details below.